{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:49:00Z","timestamp":1789501740772,"version":"build-2803163510"},"reference-count":17,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.2967\/jnumed.120.254482","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T23:00:18Z","timestamp":1612566018000},"page":"1380-1383","source":"Crossref","is-referenced-by-count":28,"title":["Prognostic Value of Bone Marrow Metabolism on Pretreatment <sup>18<\/sup>F-FDG PET\/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy"],"prefix":"10.2967","volume":"62","author":[{"given":"Ryusuke","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Zaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Arani","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Davidzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Mari","family":"Aparici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Lewis","family":"Franc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2022032307250580000_62.10.1380.1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40644-020-00313-2","article-title":"18F-FDG PET\/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma","volume":"20","author":"Wong","year":"2020","journal-title":"Cancer Imaging."},{"key":"2022032307250580000_62.10.1380.2","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00259-020-04792-0","article-title":"Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy","volume":"47","author":"Nakamoto","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022032307250580000_62.10.1380.3","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00259-019-04411-7","article-title":"Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics","volume":"46","author":"Seban","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022032307250580000_62.10.1380.4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00259-018-4211-0","article-title":"Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in melanoma patients treated with ipilimumab therapy","volume":"46","author":"Ito","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022032307250580000_62.10.1380.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70263-3"},{"key":"2022032307250580000_62.10.1380.6","doi-asserted-by":"crossref","first-page":"e1574197","DOI":"10.1080\/2162402X.2019.1574197","article-title":"Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy","volume":"8","author":"Seban","year":"2019","journal-title":"OncoImmunology."},{"key":"2022032307250580000_62.10.1380.7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/jcm8081169","article-title":"Effect of F-18 fluorodeoxyglucose uptake by bone marrow on the prognosis of head and neck squamous cell carcinoma","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med."},{"key":"2022032307250580000_62.10.1380.8","first-page":"559","article-title":"Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non\u2013small cell lung cancer","volume":"47","author":"Pr\u00e9vost","year":"2006","journal-title":"J Nucl Med."},{"key":"2022032307250580000_62.10.1380.9","doi-asserted-by":"crossref","first-page":"iv369","DOI":"10.1093\/annonc\/mdu342.23","article-title":"Adaptation of the immune related response criteria: irRECIST [abstract]","volume":"25","author":"Bohnsack","year":"2014","journal-title":"Ann Oncol."},{"key":"2022032307250580000_62.10.1380.10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00330-016-4568-z","article-title":"The role of 18F-fluorodeoxyglucose uptake of bone marrow on PET\/CT in predicting clinical outcomes in non-small cell lung cancer patients treated with chemoradiotherapy","volume":"27","author":"Lee","year":"2017","journal-title":"Eur Radiol."},{"key":"2022032307250580000_62.10.1380.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2006.09.005"},{"key":"2022032307250580000_62.10.1380.12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7150\/jca.11348","article-title":"Longitudinal FDG-PET revealed regional functional heterogeneity of bone marrow, site-dependent response to treatment and correlation with hematological parameters","volume":"6","author":"Yagi","year":"2015","journal-title":"J Cancer."},{"key":"2022032307250580000_62.10.1380.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature04186"},{"key":"2022032307250580000_62.10.1380.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00153-8"},{"key":"2022032307250580000_62.10.1380.15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12013-015-0528-5","article-title":"Bioengineered colorectal cancer drugs: orally delivered anti-inflammatory agents","volume":"72","author":"Urbanska","year":"2015","journal-title":"Cell Biochem Biophys."},{"key":"2022032307250580000_62.10.1380.16","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000538"},{"key":"2022032307250580000_62.10.1380.17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7150\/thno.35989","article-title":"Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in\u00a0vivo 18F-FDG-PET","volume":"10","author":"Schwenck","year":"2020","journal-title":"Theranostics."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.254482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T14:30:12Z","timestamp":1648045812000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.254482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.2967\/jnumed.120.254482"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.254482","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]}}}